Literature DB >> 46348

Letter: The pineal and neoplasia.

R S Buswell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 46348     DOI： 10.1016/s0140-6736(75)92390-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  The contribution of extrapineal sites of melatonin synthesis to circulating melatonin levels in higher vertebrates.

Authors:  G Huether
Journal:  Experientia       Date:  1993-08-15

2.  Melatonin as a tumour marker in a patient with pineal tumour.

Authors:  S G Barber; J A Smith; R C Hughes
Journal:  Br Med J       Date:  1978-07-29

3.  Pineal gland and polyamines.

Authors:  F Fraschini; M E Ferioli; R Nebuloni; G Scalabrino
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

Review 4.  Pineal effects on metabolism and glucose homeostasis: evidence for lines of humoral mediation of pineal influences on tumor growth.

Authors:  W B Quay; K C Gorray
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

5.  Effect of melatonin on experimental tumors under different photoperiods and times of administration.

Authors:  H Bartsch; C Bartsch
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

6.  A clinical study on the relationship between the pineal gland and the opioid system.

Authors:  P Lissoni; D Esposti; G Esposti; R Mauri; M Resentini; F Morabito; P Fumagalli; A Santagostino; G Delitala; F Fraschini
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

7.  Urinary melatonin levels in human breast cancer patients.

Authors:  C Bartsch; H Bartsch; A K Jain; K R Laumas; L Wetterberg
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

8.  Serum interleukin-2 levels in relation to the neuroendocrine status in cancer patients.

Authors:  P Lissoni; G Tancini; F Rovelli; G Cattaneo; C Archili; S Barni
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

Review 9.  Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.

Authors:  Russel J Reiter; Sergio A Rosales-Corral; Dun-Xian Tan; Dario Acuna-Castroviejo; Lilan Qin; Shun-Fa Yang; Kexin Xu
Journal:  Int J Mol Sci       Date:  2017-04-17       Impact factor: 5.923

Review 10.  The psychoneuroendocrine-immunotherapy of cancer: Historical evolution and clinical results.

Authors:  Paolo Lissoni; Giusy Messina; Arianna Lissoni; Rovelli Franco
Journal:  J Res Med Sci       Date:  2017-04-26       Impact factor: 1.852
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.